申请人:Abbott Laboratories
公开号:US05340802A1
公开(公告)日:1994-08-23
Peptide analog type-B CCK receptor ligands or pharmaceutically-acceptable salts thereof, which are useful for treating central nervous system disorders, substance abuse, gastrointestinal disorders, endocrine disorders, eating-related disorders and for the treatment of shock, respiratory and cardiocirculatory insufficiencies.
肽类模拟物B型CCK受体配体或其药学上可接受的盐,可用于治疗中枢神经系统疾病、物质滥用、胃肠道疾病、内分泌失调、进食相关障碍以及休克、呼吸和心血管功能不足的治疗。